Healthy Living

Ability to Identify Genetic Type of Lymphoma Can Lead to Better Treatment Accuracy

Eventually, completely individualized therapy could be the norm

Precision medicine clinical trials could test tumors for the new genetic subtypes, Dr. Staudt explained, and then, based on the tumor's classification, the patient would be assigned to the most appropriate treatment arm of the study.
"The goal is to find the right drug for the right person at the right time," said Dr. Staudt. "And we feel this genetic understanding of diffuse lymphoma is a step forward in precision therapy."

References

https://lymphomanewstoday.com/2018/04/17/new-dlbcl-genetic-subtypes-offer-potential-for-tailored-therapies/

https://www.cancer.gov/news-events/press-releases/2018/lymphoma-genetic-subtypes